Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [18F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression - Patel CB; Beinat C; Xie Y; Chang E; Gambhir SS (Neoplasia, 2021)
FEMU ID: 43745; EMF-Portal URL: https://www.emf-portal.org/en/article/43745